Antibody data
- Antibody Data
- Antigen structure
- References [4]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 68035-1-Ig - Provider product page

- Provider
- Proteintech Group
- Product name
- PGK1 antibody
- Antibody type
- Monoclonal
- Description
- PGK1 antibody (Cat. #68035-1-Ig) is a mouse monoclonal antibody that shows reactivity with Human and has been validated for the following applications: WB, ELISA.
- Reactivity
- Human
- Host
- Mouse
- Conjugate
- Unconjugated
- Isotype
- IgG
- Antibody clone number
- 1B2F3
- Vial size
- 20ul, 150ul
Submitted references PGK1/PHGDH axis drives radioresistance in glioblastoma stem cells.
Hypoxia-inducible factor-1 alpha modulates muscle growth and the molting process through its regulation of glycolysis in Neocaridina davidi.
Phosphoglycerate kinase 1 contributes to diabetic kidney disease through enzyme-dependent and independent manners.
Tetraarsenic tetrasulfide triggers ROS-induced apoptosis and ferroptosis in B-cell acute lymphoblastic leukaemia by targeting HK2.
Cheng Z, Ding F, Yin J, Wang Y, Gao Y, Ge X, Zhang J, Wang X, Zhao M, Zhao N, Shu C, Wang X, Qian X, Qian C, Ji J, You Y, Shi Z
Cancer letters 2026 Jul 10;650:218517
Cancer letters 2026 Jul 10;650:218517
Hypoxia-inducible factor-1 alpha modulates muscle growth and the molting process through its regulation of glycolysis in Neocaridina davidi.
Li R, Hu L, Zhou R, Zhou J, Yang J, Wang M, Sun J
The Journal of biological chemistry 2025 Jul;301(7):110298
The Journal of biological chemistry 2025 Jul;301(7):110298
Phosphoglycerate kinase 1 contributes to diabetic kidney disease through enzyme-dependent and independent manners.
Sun HJ, Lu QB, Liu SJ, Fu X, Yu CL, Su JB, Meng XY, Guo X, Shao X, Li JH, Sun QY, Zhu XX, Shan JJ, Zhou W
Cell reports. Medicine 2025 Aug 19;6(8):102241
Cell reports. Medicine 2025 Aug 19;6(8):102241
Tetraarsenic tetrasulfide triggers ROS-induced apoptosis and ferroptosis in B-cell acute lymphoblastic leukaemia by targeting HK2.
Bai W, Liu D, Cheng Q, Yang X, Zhu L, Qin L, Fang J
Translational oncology 2024 Feb;40:101850
Translational oncology 2024 Feb;40:101850
No comments: Submit comment
No validations: Submit validation data